Literature DB >> 26535975

Association of Metabolic Syndrome with Chronic Kidney Disease in Elderly Japanese Women: Comparison by Estimation of Glomerular Filtration Rate from Creatinine, Cystatin C, and Both.

Miki Kurata1,2, Ayaka Tsuboi2, Mika Takeuchi1, Keisuke Fukuo1,2,3, Tsutomu Kazumi2.   

Abstract

BACKGROUND: Associations between metabolic syndrome (MetS) and chronic kidney disease (CKD) has not been extensively studied in elderly Asians, who in general have lower body mass index (BMI) than European populations.
METHODS: A cross-sectional analysis was conducted including 159 community-living elderly Japanese women. MetS was defined by the modified National Cholesterol Education Program Adult Treatment Panel III criteria, but using a BMI ≥25 kg/m(2) instead of waist circumference and renal function was assessed according to the Kidney Disease Outcomes Quality Initiative CKD classification. Creatinine-based and cystatin C-based estimated glomerular filtration rate (eGFR) and the average of the two eGFRS were used.
RESULTS: Prevalence of CKD was much higher when creatinine-based eGFR was used than the prevalence obtained when cystatin-C based equations were used (46.5% vs. 12.6%, P < 0.001). Eighteen (11.3%) women met MetS criteria. Both the presence of MetS and the number of MetS components were associated with higher prevalence of CKD using the average eGFR (all P < 0.05) but not using creatinine-based (P = 0.86) and cystatin C-based (P = 0.12) eGFR alone. Lower average eGFR and higher prevalence of CKD using average eGFR were evident in even women with only one MetS component, 89% of whom had elevated blood pressure.
CONCLUSIONS: Prevalence of CKD varied substantially depending on the used equation. In nonobese, elderly Japanese women, both the presence of MetS and the number of MetS components were associated with higher prevalence of CKD and elevated blood pressure may play an important role in these associations. These findings should be confirmed in studies employing more participants with MetS diagnosed using standard criteria (waist circumference instead of BMI).

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26535975     DOI: 10.1089/met.2015.0085

Source DB:  PubMed          Journal:  Metab Syndr Relat Disord        ISSN: 1540-4196            Impact factor:   1.894


  6 in total

1.  Effect of coexisting diabetes mellitus and chronic kidney disease on mortality of cirrhotic patients with esophageal variceal bleeding.

Authors:  Chia-Chi Lung; Zhi-Hong Jian; Jing-Yang Huang; Oswald Ndi Nfor
Journal:  BMC Gastroenterol       Date:  2016-02-29       Impact factor: 3.067

2.  Metabolic Syndrome and Chronic Renal Disease.

Authors:  Vaia D Raikou; Sotiris Gavriil
Journal:  Diseases       Date:  2018-01-24

3.  The Cluster of Abnormalities Related to Metabolic Syndrome Is Associated With Reduced Glomerular Filtration Rate and Raised Albuminuria in Patients With Type 2 Diabetes Mellitus.

Authors:  Miki Kurata; Akiko Takenouchi; Ayaka Tsuboi; Satomi Minato; Mika Takeuchi; Kaori Kitaoka; Keisuke Fukuo; Tsutomu Kazumi
Journal:  J Clin Med Res       Date:  2017-07-27

4.  Elevated serum adiponectin and tumor necrosis factor-α and decreased transthyretin in Japanese elderly women with low grip strength and preserved muscle mass and insulin sensitivity.

Authors:  Mika Takeuchi; Ayaka Tsuboi; Satomi Minato; Megumu Yano; Kaori Kitaoka; Miki Kurata; Tsutomu Kazumi; Keisuke Fukuo
Journal:  BMJ Open Diabetes Res Care       Date:  2018-09-05

5.  Metabolic Syndrome Is Associated With Rapid Estimated Glomerular Filtration Rate Decline In A Chinese Community-Based Population.

Authors:  Zhongli Wu; Yimeng Jiang; Jia Jia; Danmei He; Pengfei Sun; Jianping Li; Yong Huo; Fangfang Fan; Yan Zhang
Journal:  Diabetes Metab Syndr Obes       Date:  2019-10-11       Impact factor: 3.168

6.  Changes in metabolic syndrome status affect the incidence of end-stage renal disease in the general population: a nationwide cohort study.

Authors:  Eun Sil Koh; Kyung Do Han; Mee Kyoung Kim; Eun Sook Kim; Min-Kyung Lee; Ga Eun Nam; Oak-Kee Hong; Hyuk-Sang Kwon
Journal:  Sci Rep       Date:  2021-01-21       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.